fbpx

Female, 41 y/o

Patient internal ID: 75735747

ICD-10 code

C47.0 Malignant Neoplasm: Peripheral Nerves of Head, Face, and Neck

Diagnosis (incl metastases/stage) and year

December 2019
Malignant Peripheral Nerve Sheath Tumor pT3 N0M0, LVI (1), Ki67 – 30%. G3, No Lymph Node Metastases.

Previous treatment

Surgery, Radiation Therapy.

Prognosis and survival expectation

The pooled data of 22 studies suggests that Malignant Peripheral Nerve Sheath Tumor 5-year overall survival rate was around 49%.

Treatment provided

Autologous DCV (8 doses) and CIK (4 doses) over a period of 11 months.
Additionally, the patient received Xenogeneic Preventive and Therapeutic Anti-Cancer Vaccine (PTAC) (10 vaccines) as well as Umbilical Cord Blood Derived NK cells (4 doses).

Patient survival/condition and year

The patient has survived for 47 months so far, has no signs of disease and has regular check-ups with his oncologist. It can be concluded that the addition of Immunotherapy, alongside Surgery and Radiation Therapy, caused noticeable disease regression and stabilisation.

Date of Review

01/11/2023